The role of alpha-adrenoreceptors in the treatment of urological diseases

Neurochemistry International

Volumn 51, Issue 5, 2007, Pages 328-331

  Romics, Imre ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Alpha adrenoreceptor blocker; Benignus prostata hyperplasia; Prostatitis; Ureter stone

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; DEFLAZACORT; DOXAZOSIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT; SPASMOLYTIC AGENT; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TERAZOSIN;

ARTICLE; BLADDER CONTRACTION; BLADDER EMPTYING; BLADDER NECK STENOSIS; EXTRACORPOREAL LITHOTRIPSY; HUMAN; MUSCLE TONE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATITIS; RESIDUAL URINE; TREATMENT INDICATION; URETER; URETER STONE; URINARY TRACT DISEASE; URINE FLOW RATE; UROLITHIASIS;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; HUMANS; MALE; PROSTATIC HYPERPLASIA; PROSTATITIS; RECEPTORS, ADRENERGIC, ALPHA; UROLITHIASIS; UROLOGIC DISEASES;

EID: 34548483698     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.05.023     Document Type: Article

References (18)

1. Berry S.J., Coffey D.S., et al. The development of human benign prostatic hyperplasia with age. J. Urol. 132 (1984) 474-479
2. de la Rosette, J.J., 2006. Guideline on benign prostate hyperplasia. EAU Guideline. 2-59.
3. Debruyne F.M. Medical management of BPH: the debate continues. Eur. Urol. 50 (2006) 416-417
4. Djavan B., and Marberger M. A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur. Urol. 36 (1999) 1-13
5. Kaplan S.A., McConnell J.D., et al. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater. J. Urol. 175 (2006) 217-220
6. Kirby R.S. Doxazosin in the treatment of the whole patient. In: Kirby R.S., McConnell J.D., Fitzpatrick J.M., Roehrbom C.G., and Boyle P. (Eds). Textbook of Benign Prostata Hyperplasia (1996), ISIS Medical Media, Oxford 288-293
7. Kupeli B., Irkilata L., et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy?. Urology 64 (2004) 1111-1115
8. Litwin M.S. A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index. Urology 60 (2002) 14-18
9. Madersbacher S., Alivizatos G., et al. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur. Urol. 46 (2004) 547-554
10. Mehik A., Alas P., et al. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 62 (2003) 425-429
11. Michel M.C., and de la Rosette J.J. Alpha-blocker treatment of urolithiasis. Eur. Urol. 50 (2006) 213-214
12. Nickel J.C. Alpha-blockers for the treatment of prostatitis-like syndromes. Rev. Urol. 8 (2006) S26-S34
13. Porpiglia F., Vaccino D., et al. Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association?. Eur. Urol. 50 (2006) 339-344
14. Roberts R.O., Jacobson D.J., et al. Prevalence of prostatitis-like symptoms in a community based cohort of older men. J. Urol. 168 (2002) 2467-2471
15. Schaeffer A.J. Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome. N. Engl. J. Med. 355 (2006) 1690-1698
16. Souverein P.C., Erkens J.A., et al. Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery. Eur. Urol. 43 (2003) 528-534
17. Witjes W.P., Rosier P.F., et al. Urodynamic and clinical effects of terazosin therapy in symptomatic patients with and without bladder outlet obstruction: a stratified analysis. Urology 49 (1997) 197-205
18. Yilmaz E., Batislam E., et al. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J. Urol. 173 (2005) 2010-2012